Targeting the vascular and perivascular niches as a regenerative therapy for lung and liver fibrosis
2017
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Targeting the vascular and perivascular niches as a regenerative therapy for lung and liver fibrosis
- Ist Teil von
- Science translational medicine, 2017-08, Vol.9 (405)
- Ort / Verlag
- United States
- Erscheinungsjahr
- 2017
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- The regenerative capacity of lung and liver is sometimes impaired by chronic or overwhelming injury. Orthotopic transplantation of parenchymal stem cells to damaged organs might reinstate their self-repair ability. However, parenchymal cell engraftment is frequently hampered by the microenvironment in diseased recipient organs. We show that targeting both the vascular niche and perivascular fibroblasts establishes "hospitable soil" to foster the incorporation of "seed," in this case, the engraftment of parenchymal cells in injured organs. Specifically, ectopic induction of endothelial cell (EC)-expressed paracrine/angiocrine hepatocyte growth factor (HGF) and inhibition of perivascular NOX4 [NADPH (reduced form of nicotinamide adenine dinucleotide phosphate) oxidase 4] synergistically enabled reconstitution of mouse and human parenchymal cells in damaged organs. Reciprocally, genetic knockout of in mouse ECs ( ) aberrantly up-regulated perivascular NOX4 during liver and lung regeneration. Dysregulated HGF and NOX4 pathways subverted the function of vascular and perivascular cells from an epithelially inductive niche to a microenvironment that inhibited parenchymal reconstitution. Perivascular NOX4 induction in mice recapitulated the phenotype of human and mouse liver and lung fibrosis. Consequently, EC-directed HGF and NOX4 inhibitor GKT137831 stimulated regenerative integration of mouse and human parenchymal cells in chronically injured lung and liver. Our data suggest that targeting dysfunctional perivascular and vascular cells in diseased organs can bypass fibrosis and enable reparative cell engraftment to reinstate lung and liver regeneration.
- Sprache
- Englisch
- Identifikatoren
- eISSN: 1946-6242DOI: 10.1126/scitranslmed.aai8710Titel-ID: cdi_pubmed_primary_28855398
- Format
- –
- Schlagworte
- Endothelial Cells - drug effects, Endothelial Cells - metabolism, Epithelial Cells - transplantation, Fibroblasts - drug effects, Fibroblasts - metabolism, Fibroblasts - pathology, Hepatocyte Growth Factor - pharmacology, Hepatocytes - drug effects, Hepatocytes - metabolism, Humans, Liver Cirrhosis - pathology, Liver Cirrhosis - therapy, Liver Regeneration - drug effects, NADPH Oxidase 4 - antagonists & inhibitors, NADPH Oxidase 4 - metabolism, Neovascularization, Physiologic - drug effects, Parenchymal Tissue - transplantation, Pulmonary Alveoli - pathology, Pulmonary Fibrosis - pathology, Pulmonary Fibrosis - therapy, Regenerative Medicine